# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | Aciclovir | 13 | Vduss | = | 9.81 | L/Kg | ALA1034577 | L.kg-1 | Equus caballus | |||
2. | Aciclovir | 13 | MRT | = | 7.09 | hr | ALA1023565 | hr | Equus caballus | |||
3. | Aciclovir | 13 | beta t1/2 | = | 9.6 | hr | ALA1023564 | hr | Equus caballus | |||
4. | Aciclovir | 13 | AUC | = | 19.2 | microg.hr/mL | ALA1023563 | ng.hr.mL-1 | Equus caballus | |||
5. | Aciclovir | 13 | Cmax | = | 10.4 | ug ml-1 | ALA1023562 | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | nM | Equus caballus | ||
6. | Aciclovir | 13 | F | = | 2.8 | % | ALA1023557 | % | Equus caballus | |||
7. | Aciclovir | 13 | Vdss | = | 3.54 | L/Kg | ALA1023556 | L.kg-1 | Equus caballus | |||
8. | Aciclovir | 13 | CL | = | 0.3 | L/hr | ALA1023555 | L/hr | Equus caballus | |||
9. | Aciclovir | 13 | AUC | = | 37.3 | microg.hr/mL | ALA1023554 | ng.hr.mL-1 | Equus caballus | |||
10. | Aciclovir | 13 | Cmax | = | 46.2 | ug ml-1 | ALA1023553 | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | standard_value was converted from ug.mL-1 to nM using the parent compound MW | nM | Equus caballus | ||
11. | Aciclovir | 13 | Cp | = | 50 | ng/ml | ALA1023552 | ng/ml | Equus caballus | |||
12. | ALA1349 | Valaciclovir | F | = | 26.4 | % | ALA1023547 | % | Equus caballus | |||
13. | ALA1349 | Valaciclovir | F | = | 26.1 | % | ALA1023546 | % | Equus caballus | |||
14. | ALA1349 | Valaciclovir | fAUC | = | 14.9 | ug.hr/ml | ALA1034589 | ng.hr.mL-1 | Equus caballus | |||
15. | ALA1349 | Valaciclovir | AUC | = | 10 | microg.hr/mL | ALA1034588 | ng.hr.mL-1 | Equus caballus | |||
16. | ALA1349 | Valaciclovir | beta t1/2 | = | 8.79 | hr | ALA1034587 | hr | Equus caballus | |||
17. | ALA1349 | Valaciclovir | beta t1/2 | = | 2.03 | hr | ALA1034586 | hr | Equus caballus | |||
18. | ALA1349 | Valaciclovir | fTmax | = | 0.78 | hr | ALA1034585 | hr | Equus caballus | |||
19. | ALA1349 | Valaciclovir | Tmax | = | 0.9 | hr | ALA1034584 | hr | Equus caballus | |||
20. | ALA1349 | Valaciclovir | fCmax | = | 4.76 | ug ml-1 | ALA1034583 | ug ml-1 | Equus caballus |